Quality control reagents and methods

US10900939B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10900939-B2
Application numberUS-201916275417-A
CountryUS
Kind codeB2
Filing dateFeb 14, 2019
Priority dateFeb 13, 2013
Publication dateJan 26, 2021
Grant dateJan 26, 2021

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention provides reagents for instrumentation quality control and methods of use thereof. In particular, sets of peptides or other molecules are provided for evaluating the performance of instruments with mass spectrometry (MS) and/or liquid chromatography (LC) functionalities.

First claim

Opening claim text (preview).

The invention claimed is: 1. A method for assessing performance of an instrument with both liquid chromatography (LC) and mass spectrometry (MS) functionalities comprising: (a) introducing a neat peptide mixture in the absence of other background causing peptides into the instrument, wherein the neat peptide mixture comprises three or more distinct-mass isotopologues of each of three or more distinct peptide sequences, wherein two or more of the distinct-mass isotopologues of each of the three or more distinct peptide sequences comprises one or more amino acids with above natural abundance levels of one or more heavy isotopes; (b) separating or analyzing the peptide mixture by LC; and (c) analyzing the peptide mixture by MS; wherein there is a linear relationship between the relative MS intensity versus the molar amount of the isotopologues for each distinct peptide sequence. 2. The method of claim 1 , wherein each of the distinct peptide sequences is of distinct hydrophobicity. 3. The method of claim 1 , wherein all of the distinct-mass isotopologues of any of the distinct peptide sequences are present at distinct concentrations. 4. The method of claim 1 , wherein the distinct-mass isotopologues of any of the distinct peptide sequences are present at concentrations ranging from at least as low as 1 nM to at least as high at 10 μM. 5. The method of claim 4 , wherein the distinct-mass isotopologues of any of the distinct peptide sequences are present at concentrations ranging from at least as low as 10 nM to at least as high at 1 μM. 6. The method of claim 1 , wherein the distinct peptide sequences are separable by liquid chromatography based on their different hydrophobicities. 7. The method of claim 1 , wherein the distinct peptide sequences are separable by liquid chromatography based on their different charge, size, or hydrophilicity. 8. The method of claim 1 , comprising 3-20 distinct-sequence peptides. 9. The method of claim 8 , comprising 5-10 distinct peptide sequences. 10. The method of claim 1 , wherein the distinct-mass isotopologues of any of the distinct peptide sequences are differentiable by mass spectrometry. 11. The method of claim 1 , wherein the distinct-mass isotopologues of any of the distinct peptide sequences are the result of different combinations of stable heavy isotope-labeled amino acids. 12. The method of claim 1 , wherein each of the distinct-mass isotopologues of any of the distinct peptide sequences comprises a different number of uniformly stable isotope-labeled amino acids. 13. The method of claim 1 , comprising 3-20 distinct-mass isotopologues of each of the distinct peptide sequences. 14. The method of claim 13 , comprising 5-10 distinct-mass isotopologues of each of the distinct peptide sequences. 15. The method of claim 1 , wherein MS is MS/MS. 16. The method of claim 1 , further comprising: (d) assessing the performance of the LC and MS functionalities of the instrument based on the analyses of steps (b) and (c). 17. The method of claim 1 , further comprising: (d) repeating steps (a)-(c) at a second time point; (e) comparing results of steps (b)-(c) at the first and second time points; and (f) assessing the performance of the LC and MS functionalities of the instrument over time based on the comparison of step (e). 18. A method for determining the dynamic range of an instrument with both liquid chromatography (LC) and mass spectrometry (MS) functionalities comprising: (a) introducing a neat peptide mixture in the absence of other background causing peptides into the instrument, wherein the neat peptide mixture comprises three or more distinct-mass isotopologues of each of three or more distinct peptide sequences wherein two or more of the distinct-mass isotopologues of each of the three or more distinct peptide sequences comprises one or more amino acids with above natural abundance levels of one or more heavy isotopes; (b) separating or analyzing the peptide mixture by LC; and (c) analyzing the peptide mixture by MS; wherein the dynamic range of the instrument extends over the range for which there is a linear relationship between the relative MS intensity versus the molar amount of the isotopologues for each distinct peptide sequence.

Assignees

Inventors

Classifications

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10900939B2 cover?
The present invention provides reagents for instrumentation quality control and methods of use thereof. In particular, sets of peptides or other molecules are provided for evaluating the performance of instruments with mass spectrometry (MS) and/or liquid chromatography (LC) functionalities.
Who is the assignee on this patent?
Promega Corp
What technology area does this patent fall under?
Primary CPC classification G01N30/8665. Mapped technology areas include Physics.
When was this patent published?
Publication date Tue Jan 26 2021 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 5 related publications on this page (citations in our corpus or others sharing the same primary CPC).